Infectious Disease · Sexually Transmitted Infections

Chlamydia Trachomatis Infection

USMLE2PANCE
7

Bets

The facts most likely to be tested

1

Chlamydia trachomatis is the most common bacterial sexually transmitted infection in the United States and is frequently asymptomatic in both men and women.

Confidence:
2

Nucleic acid amplification testing (NAAT) is the gold standard diagnostic test for urogenital chlamydial infections using first-catch urine or vaginal swabs.

Confidence:
3

Doxycycline (100 mg twice daily for 7 days) is the first-line treatment for uncomplicated urogenital chlamydia in non-pregnant adults.

Confidence:
4

Azithromycin (1 g orally in a single dose) is the preferred treatment for chlamydia in pregnant patients to avoid the teratogenic effects of tetracyclines.

Confidence:
5

Lymphogranuloma venereum (LGV), caused by serovars L1-L3, presents with a painless genital ulcer followed by painful, matted inguinal lymphadenopathy known as buboes.

Confidence:
6

Fitz-Hugh-Curtis syndrome is a rare complication of pelvic inflammatory disease (PID) characterized by perihepatitis and 'violin-string' adhesions on the liver capsule.

Confidence:
7

Neonatal conjunctivitis caused by Chlamydia trachomatis typically presents 5-14 days after birth and is treated with systemic oral erythromycin.

Confidence:

Vignette unlocked

A 22-year-old female presents to the clinic for a routine check-up. She reports no symptoms but mentions she has a new sexual partner and does not consistently use barrier protection. On physical exam, there is no cervical motion tenderness or adnexal masses. A cervical swab is collected for NAAT. Two days later, the laboratory reports a positive result for Chlamydia trachomatis.

What is the most appropriate management for this patient's sexual partner?

+Reveal answer

Expedited partner therapy (EPT) or referral for presumptive treatment

This tests the requirement for partner notification and treatment to prevent reinfection, which is a core component of managing sexually transmitted infections.

Mo

Depth

Full handout

High yield triage

Etiology / Epidemiology

Most common bacterial STI in the US; highest incidence in sexually active adults <25 years old.

Clinical Manifestations

Often asymptomatic; classic presentation includes mucopurulent cervicitis and Fitz-Hugh-Curtis syndrome.

Diagnosis

Nucleic acid amplification test (NAAT) is the gold standard; use first-catch urine or swab.

Treatment

Doxycycline is the first-line treatment; avoid in pregnancy.

Prognosis

Untreated infection leads to pelvic inflammatory disease (PID) and infertility.

Full handout

Epidemiology & Etiology

Caused by the obligate intracellular bacterium Chlamydia trachomatis (serotypes D-K). It is the most frequently reported notifiable disease in the United States. Primary risk factors include multiple sexual partners, inconsistent condom use, and a history of prior STIs.

Pertinent Anatomy

Infection primarily targets the columnar epithelium of the endocervix, urethra, and rectum. In neonates, the organism can infect the conjunctiva and respiratory tract during passage through the birth canal.

Pathophysiology

The organism exists as an elementary body (infectious) and a reticulate body (replicative). It induces a pro-inflammatory cytokine response leading to tissue damage and scarring. Chronic inflammation results in the characteristic tubal scarring associated with ectopic pregnancy and infertility.

Clinical Manifestations

Most patients are asymptomatic, but women may present with post-coital bleeding or mucopurulent cervicitis. Men typically present with urethritis (dysuria, clear/cloudy discharge). Red flags include pelvic pain (PID) or Fitz-Hugh-Curtis syndrome (perihepatitis), which presents as RUQ pain mimicking gallbladder disease.

Diagnosis

The Nucleic acid amplification test (NAAT) is the gold standard for diagnosis due to high sensitivity and specificity. Specimens are collected via vaginal swab or first-catch urine in men. Screening is recommended annually for all sexually active women <25 years old.

Treatment

Doxycycline (100 mg BID for 7 days) is the first-line treatment for non-pregnant adults. In pregnancy, Azithromycin (1g single dose) is the preferred agent. Contraindications for Doxycycline include pregnancy due to potential for fetal tooth discoloration and bone growth inhibition.

Prognosis

Untreated infection carries a high risk of pelvic inflammatory disease (PID), which occurs in 10-15% of untreated cases. Long-term sequelae include tubal factor infertility and ectopic pregnancy. Patients must be counseled on partner notification and abstinence until treatment is completed.

Differential Diagnosis

Gonorrhea: typically presents with more purulent discharge

Trichomoniasis: presents with strawberry cervix and frothy discharge

Bacterial Vaginosis: presents with clue cells and fishy odor

Herpes Simplex: presents with painful vesicles and ulcerations

PID: presents with cervical motion tenderness